Publications by authors named "Scott Askin"

Claim this Profile
R
Recommendation Paper on Advancing the Use of Decentralised Elements in Clinical Trials.
Alison Bond, Tracey Robertson, Christine Fletcher, Elizabeth Theogaraj, Greg Jordinson, Scott Askin

Ther Innov Regul Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Interactions and Learnings-RADIAL the Trials@Home Proof-of-Concept Trial on Decentralization.
Helga Gardarsdottir, Hamidou Traore, Kate Huntley, Dinesh Mistry, Amos J de Jong, Scott Askin

Clin Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving regulatory perspectives on digital health technologies for medicinal product development.
Seya Colloud, Thomas Metcalfe, Scott Askin, Shibeshih Belachew, Johannes Ammann

NPJ Digit Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Applied to clinical trials: opportunities and challenges.
Scott Askin, Denis Burkhalter, Gilda Calado, Samar El Dakrouni

Health Technol (Berl)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' Perspective.
Amos J de Jong, Tessa I van Rijssel, Mira G P Zuidgeest, Ghislaine J M W van Thiel, Scott Askin

Clin Pharmacol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital technologies for medicines: shaping a framework for success.
Francesca Cerreta, Armin Ritzhaupt, Thomas Metcalfe, Scott Askin, João Duarte

Nat Rev Drug Discov· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting.
Philipp Bruland, Mark McGilchrist, Eric Zapletal, Dionisio Acosta, Johann Proeve, Scott Askin

BMC Med Res Methodol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis